Valentine Richez

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Elodie Tournay et al. · Journal of Clinical Oncology · 2019 · 179 citations · Full text

Medicine, Hematology, Oncology +16

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

Artur Jurczyszyn, Jakub Radocha, Julio Dávila et al. · British Journal of Haematology · 2018 · 67 citations · Full text

Medicine, Hematology, Oncology +8

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

Mohamed-Amine Hamouda, Arnaud Jacquel, Guillaume Robert et al. · The Journal of Experimental Medicine · 2016 · 31 citations · Full text

Medicine, Cell Biology, Oncology +15

Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience

Alexis Caulier, Murielle Roussel, Pierre Morel et al. · Blood · 2021 · 31 citations · Full text

Medicine, Hematology, Oncology +15

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial

Aurore Perrot, Cyrille Touzeau, Jérôme Lambert et al. · Blood · 2025 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17